S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
New Trump Bombshell (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
New Trump Bombshell (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
New Trump Bombshell (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
New Trump Bombshell (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
New Trump Bombshell (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
New Trump Bombshell (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
New Trump Bombshell (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
New Trump Bombshell (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
New Trump Bombshell (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
New Trump Bombshell (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
New Trump Bombshell (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
New Trump Bombshell (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage

Treace Medical Concepts (TMCI) Competitors

$14.25
-0.14 (-0.97%)
(As of 02/23/2024 08:54 PM ET)

TMCI vs. MDXG, SIBN, EMBC, AORT, FNA, KIDS, SILK, ATRI, NVRO, and IRMD

Should you be buying Treace Medical Concepts stock or one of its competitors? The main competitors of Treace Medical Concepts include MiMedx Group (MDXG), SI-BONE (SIBN), Embecta (EMBC), Artivion (AORT), Paragon 28 (FNA), OrthoPediatrics (KIDS), Silk Road Medical (SILK), Atrion (ATRI), Nevro (NVRO), and IRadimed (IRMD). These companies are all part of the "medical" sector.

Treace Medical Concepts vs.

MiMedx Group (NASDAQ:MDXG) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, community ranking, valuation, institutional ownership and profitability.

MiMedx Group received 7 more outperform votes than Treace Medical Concepts when rated by MarketBeat users. Likewise, 75.00% of users gave MiMedx Group an outperform vote while only 62.16% of users gave Treace Medical Concepts an outperform vote.

CompanyUnderperformOutperform
MiMedx GroupOutperform Votes
30
75.00%
Underperform Votes
10
25.00%
Treace Medical ConceptsOutperform Votes
23
62.16%
Underperform Votes
14
37.84%

43.9% of MiMedx Group shares are held by institutional investors. Comparatively, 61.9% of Treace Medical Concepts shares are held by institutional investors. 19.9% of MiMedx Group shares are held by company insiders. Comparatively, 28.7% of Treace Medical Concepts shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

MiMedx Group has a net margin of -0.82% compared to MiMedx Group's net margin of -27.28%. Treace Medical Concepts' return on equity of 0.00% beat MiMedx Group's return on equity.

Company Net Margins Return on Equity Return on Assets
MiMedx Group-0.82% N/A -0.72%
Treace Medical Concepts -27.28%-37.68%-21.22%

MiMedx Group has higher revenue and earnings than Treace Medical Concepts. MiMedx Group is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MiMedx Group$267.84M3.56-$30.20M-$0.02-410.00
Treace Medical Concepts$141.84M6.20-$42.81M-$0.79-18.04

In the previous week, MiMedx Group had 5 more articles in the media than Treace Medical Concepts. MarketBeat recorded 10 mentions for MiMedx Group and 5 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.02 beat MiMedx Group's score of -0.07 indicating that MiMedx Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MiMedx Group
2 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Treace Medical Concepts
0 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

MiMedx Group has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 0.28, indicating that its share price is 72% less volatile than the S&P 500.

MiMedx Group currently has a consensus target price of $11.67, indicating a potential upside of 42.28%. Treace Medical Concepts has a consensus target price of $19.58, indicating a potential upside of 37.43%. Given Treace Medical Concepts' stronger consensus rating and higher possible upside, analysts clearly believe MiMedx Group is more favorable than Treace Medical Concepts.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MiMedx Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Treace Medical Concepts
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

Summary

MiMedx Group beats Treace Medical Concepts on 13 of the 18 factors compared between the two stocks.


Get Treace Medical Concepts News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TMCI vs. The Competition

MetricTreace Medical ConceptsMedical Devices IndustryMedical SectorNASDAQ Exchange
Market Cap$878.88M$2.01B$5.16B$7.54B
Dividend YieldN/A2.18%2.87%3.86%
P/E Ratio-18.04201.06233.4018.37
Price / Sales6.20291.693,074.8769.76
Price / CashN/A15.1599.7154.97
Price / Book13.074.624.424.60
Net Income-$42.81M$38.24M$114.48M$207.21M
7 Day Performance-8.18%-3.00%0.87%-1.09%
1 Month Performance9.95%-0.97%7.08%3.27%
1 Year Performance-34.90%0.78%10.20%5.59%

Treace Medical Concepts Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDXG
MiMedx Group
2.6879 of 5 stars
$8.04
-0.2%
$11.67
+45.1%
+82.2%$935.70M$267.84M-402.00867Upcoming Earnings
SIBN
SI-BONE
3.8424 of 5 stars
$20.80
-0.6%
$26.33
+26.6%
+19.1%$842.40M$106.41M-17.48357
EMBC
Embecta
2.8534 of 5 stars
$14.30
-1.2%
$16.00
+11.9%
-52.6%$823.38M$1.12B15.052,200Positive News
AORT
Artivion
2.1194 of 5 stars
$18.70
-0.6%
$23.50
+25.7%
+56.6%$766.70M$354M-24.931,300High Trading Volume
FNA
Paragon 28
2.3492 of 5 stars
$13.73
-1.5%
$22.33
+62.7%
-26.2%$1.14B$181.38M-16.15463Upcoming Earnings
KIDS
OrthoPediatrics
4.1131 of 5 stars
$28.79
-2.3%
$42.50
+47.6%
-35.4%$672.25M$122.29M-29.38203Upcoming Earnings
SILK
Silk Road Medical
3.4129 of 5 stars
$17.15
-6.0%
$24.91
+45.2%
-68.1%$667.82M$138.64M-11.83414Upcoming Earnings
ATRI
Atrion
3.1393 of 5 stars
$356.04
+1.1%
N/A-48.7%$626.63M$183.51M29.47722
NVRO
Nevro
2.6424 of 5 stars
$17.19
-0.8%
$24.00
+39.6%
-52.1%$622.45M$406.36M-6.011,087Analyst Revision
IRMD
IRadimed
4.8679 of 5 stars
$44.90
-1.3%
$60.00
+33.6%
+13.1%$566.19M$65.56M33.01123

Related Companies and Tools

This page (NASDAQ:TMCI) was last updated on 2/26/2024 by MarketBeat.com Staff